Skip to content

Combined effect of nasal administration and topical application of eye with Draksha ghritha in Mild and Moderate Dry Eye Diseases

Combined effect of prathimarsha nasya and aschyotana with draksha ghritha in mild and moderate dry eye disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070157
Enrollment
31
Registered
2024-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H578- Other specified disorders of eye and adnexa

Interventions

None listed

Sponsors

Stisha Shyam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with mild and moderate dry eye disease Patients of age group 15 to 45 years Patients willing to give written informed consent and assent

Exclusion criteria

Exclusion criteria: Congenital alacrima Patients undergoing topical medication for any other ocular pathologies. Participants who had undergone ophthalmic surgeries within last 6 months. External ocular diseases like conjunctivitis, corneal ulcer, episcleritis and scleritis. History of use of drugs like steroids until a month prior to the study. Sjogren’s syndrome,Stevens Johnson’s syndrome Lagophthalmos, Pterygium ,bell’s palsy,Symblepharon Known case of diabetes , chronic kidney disease ,chronic liver disease , endocrine disease, cancer ,nasal polyp Contact lens users Pregnant ladies ,lactating mother

Design outcomes

Primary

MeasureTime frame
Ocular Surface Disease Index Score Timepoint: 37 days

Secondary

MeasureTime frame
Schirmer I test Tear film break up time Timepoint: 37 days

Countries

India

Contacts

Public ContactStisha Shyam

Government Ayurveda College Kannur Pariyaram

amlikavinal@gmail.com9446028794

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026